Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Porcine Nuclear Receptor Binding Protein 2 (NRBP2) Monoclonal Antibody

Cat. No.VD10N82

Product TypeAnimal-targeted Antibodies

Size 100ug

Product Overview

BioVenic mouse monoclonal antibody is specific for nuclear receptor binding protein 2. It is affinity purified by protein A. It can be applied to WB, IF, IHC and Indirect ELISA assays of nuclear receptor binding protein 2.

Specifications

Application WB; IF; IHC; Indirect ELISA
Clonality Monoclonal
Classification Primary Antibody
Clone O11N82
Host Mouse
Target Species Porcine
Species Reactivity Porcine
Specificity Nuclear Receptor Binding Protein 2
Isotype IgG2
Immunogen Recombinant protein of nuclear receptor binding protein 2
Purification Protein A Purified
Concentration 1 mg/mL
Conjugation Unconjugated
Buffer Phosphate Buffered Saline
Physical State Liquid

Target Information

Porcine nuclear receptor binding protein 2 (NRBP2) is a protein that has been identified as a tumor suppressor in various types of cancer, including breast cancer. It plays a crucial role in inhibiting the epithelial-mesenchymal transition (EMT), a process that enables cancer cells to become more mobile and invasive. NRBP2 achieves this by regulating the AMPK/mTOR signaling pathway, which is known to play a significant role in tumor proliferation and metastasis.

Target Nuclear Receptor Binding Protein 2
Target Synonym DKFZp434P086
Gene ID 110260412
UniProt ID A0A287B0S4

Shipping and Storage

This product is shipped with ice gel packs. Store at -80°C on receipt.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Xiong, Anqi, et al. "Nuclear receptor binding protein 2 is downregulated in medulloblastoma, and reduces tumor cell survival upon overexpression." Cancers 12.6 (2020): 1483.
Inquiry Basket